DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisolone (Prednisolone) - Sepsis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Sepsis (119)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 119   Next >>

Possible Prednisolone side effects in male

Reported by a physician from Germany on 2012-08-24

Patient: male, weighing 15.2 kg (33.4 pounds)

Reactions: Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ilaris
    Dosage: 60.3 mg, unk
    Indication: Juvenile Arthritis
    Start date: 2012-05-14

Prednisolone



Possible Prednisolone side effects in male

Reported by a physician from United Kingdom on 2012-08-21

Patient: male

Reactions: Pelvic Pain, Pyrexia, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Hepatosplenic T-Cell Lymphoma, Crohn's Disease, Sepsis, Platelet Count Decreased, Diabetic Ketoacidosis, Neutropenia, Rectal Discharge, Leukopenia, Influenza Like Illness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Azathioprine Sodium
    Dosage: 2.5 mg/kg
    Indication: Crohn's Disease

Azathioprine Sodium
    Start date: 2002-01-01
    End date: 2006-09-01

Azathioprine Sodium
    Start date: 2001-06-01

Mercaptopurine
    Indication: Crohn's Disease

Prednisolone
    Indication: Product Used FOR Unknown Indication

Remicade
    Indication: Crohn's Disease
    End date: 2005-09-29

Remicade
    Dosage: stopped in february - march (3rd infusion)
    End date: 2006-02-01

Other drugs received by patient: Metronidazole; Vitamin B-12



Possible Prednisolone side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-08-09

Patient: female, weighing 33.0 kg (72.6 pounds)

Reactions: Neutrophil Count Increased, Nausea, Diarrhoea, Sepsis, Asthenia, Decreased Appetite, Lymphocyte Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: daily dosage unknown
    Administration route: Oral
    Start date: 2011-01-11
    End date: 2011-03-15

Temodal
    Start date: 2011-06-22
    End date: 2011-06-26

Temodal
    Start date: 2011-01-19
    End date: 2011-03-01

Temodal

Temodal
    Start date: 2011-04-14
    End date: 2011-04-18

Temodal
    Start date: 2011-07-19
    End date: 2011-07-23

Temodal
    Start date: 2011-03-17
    End date: 2011-03-21

Temodal
    Start date: 2011-05-16
    End date: 2011-05-20

Temozolomide
    Dosage: 150 mg/m2, qd
    Start date: 2011-03-17
    End date: 2011-03-21

Temozolomide
    Dosage: 200 mg/m2, qd
    Start date: 2011-04-14
    End date: 2011-07-23

Temozolomide
    Dosage: 75 mg/m2, qd
    Indication: Anaplastic Astrocytoma
    Start date: 2011-01-19
    End date: 2011-03-01

Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Neuquinon; Neuquinon; Indomethacin; Cefazolin Sodium; Diovan; Lansoprazole; Magnesium Oxide; Granisetron; Diovan; Laxoberon; Simvastatin; Sulfamethoxazole and Trimethoprim; Neuquinon; Tegretol; Primperan TAB; Lorazepam; Prednisolone; Lansoprazole; Zolpidem; Simvastatin; Tegretol; Warfarin Sodium; Lorazepam; Urso 250; Warfarin Potassium; Warfarin Sodium



Possible Prednisolone side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from Greece on 2012-08-07

Patient: 52 year old male

Reactions: Malignant Ascites, Sepsis, General Physical Health Deterioration, non-Hodgkin's Lymphoma, Post Procedural Fistula, Respiratory Tract Infection, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mesalamine
    Indication: Crohn's Disease

Prednisolone
    Indication: Crohn's Disease



Possible Prednisolone side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-03

Patient: 42 year old male

Reactions: Blood Creatine Phosphokinase Increased, Gastrointestinal Haemorrhage, Colitis Ulcerative, Transfusion Reaction, Muscular Weakness, Condition Aggravated, Encephalitis Viral, Myalgia, Sepsis, Nervous System Disorder, Renal Tubular Necrosis, Asthenia, Deep Vein Thrombosis, Renal Failure Acute, Inflammatory Bowel Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adalimumab
    Dosage: 1 every 2 weeks for 2 doses
    Indication: Colitis Ulcerative

Adalimumab

Azathioprine Sodium
    Dosage: 50 to 150 mg once daily
    Indication: Colitis Ulcerative

Mesalamine

Mesalamine
    Administration route: Oral
    Indication: Colitis Ulcerative

Mesalamine

Prednisolone
    Dosage: 10 to 60 mg once daily
    Administration route: Oral
    Indication: Colitis Ulcerative

Probiotica
    Indication: Colitis Ulcerative

Remicade
    Indication: Colitis Ulcerative



Possible Prednisolone side effects in 77 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Pneumonia, Blood Urea Increased, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Exjade
    Dosage: 750 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-16
    End date: 2011-04-03

Exjade
    Dosage: 625 mg, on alternate days
    Administration route: Oral
    Start date: 2011-05-19

Exjade
    Dosage: 625 mg, qd
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-05-18

Prednisolone
    Dosage: 8 mg, daily
    Administration route: Oral
    End date: 2009-09-29

Prednisolone
    Dosage: 7 mg, daily
    Administration route: Oral
    Start date: 2009-09-30
    End date: 2010-02-02

Prednisolone
    Dosage: 6 mg, daily
    Administration route: Oral
    Start date: 2010-02-03
    End date: 2010-04-21

Prednisolone
    Dosage: 4 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 5 mg daily
    Administration route: Oral
    Start date: 2010-04-22

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-04-12
    End date: 2011-05-02

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-05-19
    End date: 2011-06-01

Other drugs received by patient: Platelets; Novolin R; Clarithromycin; Xalatan; Desferal; Novolin R; RED Blood Cells, Concentrated; Mucodyne; Famotidine; Famotidine; Azopt; Platelets; Desferal; RED Blood Cells, Concentrated; Alendronate Sodium; Voglibose; Timoptol-XE; Amaryl; Novolin R; Novolin R; Glufast; Glufast; Desferal; Equa



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-08-01

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Hydronephrosis, Cholecystitis Acute, Disseminated Intravascular Coagulation, Gastric Ulcer, Haemorrhage Subcutaneous, Spinal Compression Fracture, Sepsis, Platelet Count Decreased, Cholecystitis, Pyelonephritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actemra
    Start date: 2009-03-05
    End date: 2009-03-05

Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2009-02-05
    End date: 2009-02-05

Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Tacrolimus
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Crestor; Zantac; Lasix; Loxonin; Methotrexate; Alfarol; Glakay; Alendronate Sodium; Flivas; Amoban; Tamsulosin HCL; Methotrexate; Isoniazid; Vitamin B12; Folic Acid; Allopurinol



Possible Prednisolone side effects in 77 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Blood Urea Increased, Pneumonia, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Exjade
    Dosage: 625 mg, qd
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-05-18

Exjade
    Dosage: 625 mg, on alternate days
    Administration route: Oral
    Start date: 2011-05-19

Exjade
    Dosage: 750 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-16
    End date: 2011-04-03

Prednisolone
    Dosage: 5 mg daily
    Administration route: Oral
    Start date: 2010-04-22

Prednisolone
    Dosage: 8 mg, daily
    Administration route: Oral
    End date: 2009-09-29

Prednisolone
    Dosage: 7 mg, daily
    Administration route: Oral
    Start date: 2009-09-30
    End date: 2010-02-02

Prednisolone
    Dosage: 6 mg, daily
    Administration route: Oral
    Start date: 2010-02-03
    End date: 2010-04-21

Prednisolone
    Dosage: 4 mg, unk
    Administration route: Oral

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-04-12
    End date: 2011-05-02

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-05-19
    End date: 2011-06-01

Other drugs received by patient: Equa; Xalatan; Desferal; Famotidine; Novolin R; RED Blood Cells, Concentrated; Glufast; Novolin R; RED Blood Cells, Concentrated; Alendronate Sodium; Timoptol-XE; Platelets; Novolin R; Amaryl; Novolin R; Azopt; Platelets; Famotidine; Glufast; Clarithromycin; Desferal; Desferal; Mucodyne; Voglibose



Possible Prednisolone side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-31

Patient:

Reactions: Neutropenic Sepsis, Sepsis, Dyspraxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Mabthera
    Indication: Diffuse Large B-Cell Lymphoma

Mabthera
    Indication: B-Cell Lymphoma

Prednisolone
    Dosage: on day 1-5
    Indication: Diffuse Large B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



Possible Prednisolone side effects in

Reported by a consumer/non-health professional from Japan on 2012-07-27

Patient:

Reactions: Neutrophil Count Increased, Diarrhoea, Nausea, Sepsis, Asthenia, Lymphocyte Count Decreased, Decreased Appetite

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: daily dosage unknown
    Administration route: Oral
    Start date: 2011-01-11
    End date: 2011-03-15

Temodal
    Start date: 2011-05-16
    End date: 2011-05-20

Temodal
    Start date: 2011-07-19
    End date: 2011-07-23

Temodal
    Start date: 2011-06-22
    End date: 2011-06-26

Temodal
    Start date: 2011-01-19
    End date: 2011-03-01

Temodal
    Start date: 2011-03-17
    End date: 2011-03-21

Temodal
    Start date: 2011-04-14
    End date: 2011-04-18

Temodal

Temozolomide
    Dosage: 75 mg/m2, qd
    Indication: Anaplastic Astrocytoma
    Start date: 2011-01-19
    End date: 2011-03-01

Temozolomide
    Dosage: 150 mg/m2, qd
    Start date: 2011-03-17
    End date: 2011-03-21

Temozolomide
    Dosage: 200 mg/m2, qd
    Start date: 2011-04-14
    End date: 2011-07-23

Other drugs received by patient: Warfarin Sodium; Warfarin Potassium; Laxoberon; Granisetron; Tegretol; Indomethacin; Warfarin Sodium; Neuquinon; Neuquinon; Neuquinon; Lorazepam; Magnesium Oxide; Sulfamethoxazole and Trimethoprim; Diovan; Lorazepam; Tegretol; Urso 250; Zolpidem; Diovan; Simvastatin; Prednisolone; Cefazolin Sodium; Lansoprazole; Sulfamethoxazole and Trimethoprim; Lansoprazole; Primperan TAB; Simvastatin



Possible Prednisolone side effects in female

Reported by a physician from Belgium on 2012-07-19

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Multi-Organ Failure, Cardiac Failure, Sepsis, Dehydration, Muscular Weakness, Atrial Fibrillation, Asthenia, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 100 dosage forms;
    Start date: 2012-06-22

Treanda
    Start date: 2012-06-21

Other drugs received by patient: Acyclovir; Anastrozole; Atorvastatin Calcium; Pregabalin; Domperidone; Omeprazole; Ondansetron; Bisoprolol Fumarate



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 300 mg/m2

Cyclophosphamide
    Dosage: 250 mg/m2, bid for six doses
    Indication: non-Hodgkin's Lymphoma

Cytarabine
    Dosage: 100 mg/m2, daily x 5 days
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 30 mg/m2, single
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 60 mg/m2, single

Hydrocortisone Acetate
    Dosage: given with methotrexate
    Indication: non-Hodgkin's Lymphoma

Hydrocortisone Acetate
    Dosage: given with cytarabine

Methotrexate
    Dosage: 3000 mg/m2, single

Methotrexate
    Dosage: given with hydrocortisone twice x 2
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 1500 mg/m2, single

Prednisolone
    Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
    Indication: non-Hodgkin's Lymphoma

Prednisolone
    Dosage: 60 mg/m2, daily for 7 days

Rituximab
    Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg/m2, single

Vincristine
    Dosage: 1 mg/m2, single
    Indication: non-Hodgkin's Lymphoma



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-07-06

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Sepsis, Disseminated Intravascular Coagulation, Pelvic Abscess

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2009-12-15
    End date: 2011-12-22

Methotrexate Sodium
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Prednisolone
    Indication: Rheumatoid Arthritis

Other drugs received by patient: Diclofenac Sodium; Azulfidine



Possible Prednisolone side effects in 77 year old male

Reported by a consumer/non-health professional from Japan on 2012-07-06

Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-19

Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-19

Oncovin
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-08-23
    End date: 2010-08-30

Pinorubin
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-08-23
    End date: 2010-08-25

Prednisolone
    Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-31

Sprycel
    Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-06-28
    End date: 2010-08-22

Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-29

Patient: male

Reactions: Pneumonia, Staphylococcal Infection, Cardiac Failure, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Actemra
    Dosage: 560 mg hver 4. uge
    Indication: Rheumatoid Arthritis
    Start date: 2010-08-01
    End date: 2012-02-23

Methotrexate
    Indication: Rheumatoid Arthritis
    Start date: 2002-04-04

Prednisolone
    Indication: Rheumatoid Arthritis
    Start date: 2002-04-04



Possible Prednisolone side effects in female

Reported by a physician from Germany on 2012-06-28

Patient: female

Reactions: White Blood Cell Count Decreased, C-Reactive Protein Increased, Sepsis, Hypotension, Presyncope, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Doxorubicin HCL
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Mabthera
    Indication: B-Cell Lymphoma
    Start date: 2012-04-25

Neulasta
    Dosage: daily dose 6 mg, 2 x(29 apr 2012+17 may 2012
    Indication: B-Cell Lymphoma
    Start date: 2012-04-29

Prednisolone
    Dosage: frequency 1 times in 2 week for 5 days
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26
    End date: 2012-04-30

Vincristine
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Other drugs received by patient: Enoxaparin Natrium; Aspirin; Ramipril; Tiotropium Bromide; Nebivolol; Torsemide; Pantoprazole; Levothyroxine Sodium; Acyclovir; Simvastatin; Trimethoprim + Sulfamethoxazole



Possible Prednisolone side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26

Patient: female

Reactions: Syncope, Sepsis, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1493 m
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Doxorubicin HCL
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Neulasta
    Indication: B-Cell Lymphoma
    Start date: 2012-04-29

Prednisolone
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26
    End date: 2012-04-30

Rituximab
    Indication: B-Cell Lymphoma
    Start date: 2012-04-25

Vincristine
    Dosage: 3.94 m
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Other drugs received by patient: Simvastatin; Levothyroxine; Ramipril; Acyclovir; Acetylsalicylic Acid SRT; Enoxaparin Sodium; Tiotropium Bromide; Trimethoprim + Sulfamethoxazole; Torsemide; Pantoprazole; Nebivolol



Possible Prednisolone side effects in 66 year old female

Reported by a physician from Finland on 2012-06-26

Patient: 66 year old female

Reactions: Swelling Face, Nausea, Hepatic Enzyme Increased, Acute Tonsillitis, Sepsis, Neutropenia, Rash Morbilliform, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 10 mg, unk
    Indication: Seronegative Arthritis
    Start date: 2012-01-01

Sulfasalazine
    Dosage: unk
    Indication: Seronegative Arthritis
    Start date: 2012-01-01
    End date: 2012-05-01

Other drugs received by patient: Calcium Carbonate; Pantoprazole



Possible Prednisolone side effects in male

Reported by a physician from Denmark on 2012-06-25

Patient: male

Reactions: Pneumonia, Staphylococcal Infection, Cardiac Failure, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Actemra
    Dosage: dosis: 560 mg hver 4. uge
    Indication: Rheumatoid Arthritis
    Start date: 2010-08-01
    End date: 2012-02-23

Methotrexate
    Dosage: behandling stoppet pga. mors, drug reported as emthexate
    Indication: Rheumatoid Arthritis
    Start date: 2002-04-04

Prednisolone
    Dosage: behandling stoppet pga. mors
    Indication: Rheumatoid Arthritis
    Start date: 2002-04-04



Possible Prednisolone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2

Cyclophosphamide
    Dosage: 300 mg/m2 as part of cop
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: continuous infusion of 100 mg/m2 daily for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: administered once with hydrocortisone as part of cym1

Doxorubicin HCL
    Dosage: as part of copadm1
    Indication: Burkitt's Lymphoma Stage III

Doxorubicin HCL
    Dosage: as part of copadm2

Hydrocortisone
    Dosage: administered once with cytarabine as part of cym1

Hydrocortisone
    Dosage: administered with methotrexate
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm2 and cym1

Methotrexate
    Dosage: administered with hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm1

Prednisolone
    Dosage: 60 mg/m2/day for 7 days as part of cop
    Indication: Burkitt's Lymphoma Stage III

Prednisolone
    Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2

Rituximab
    Dosage: five total doses; cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm2

Vincristine
    Dosage: as part of copadm1

Vincristine
    Dosage: as part of cop
    Indication: Burkitt's Lymphoma Stage III



Possible Prednisolone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2

Cyclophosphamide
    Dosage: 300 mg/m2 as part of cop
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: continuous infusion of 100 mg/m2 daily for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: administered once with hydrocortisone as part of cym1

Doxorubicin HCL
    Dosage: as part of copadm1
    Indication: Burkitt's Lymphoma Stage III

Doxorubicin HCL
    Dosage: as part of copadm2

Hydrocortisone
    Dosage: administered with methotrexate
    Indication: Burkitt's Lymphoma Stage III

Hydrocortisone
    Dosage: administered once with cytarabine as part of cym1

Methotrexate
    Dosage: 3000 mg/m2; administered with hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm1

Methotrexate
    Dosage: as part of copadm2 and cym1

Prednisolone
    Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2

Prednisolone
    Dosage: 60 mg/m2/day for 7 days as part of cop
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: five total doses; cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm1

Vincristine
    Dosage: as part of copadm2

Vincristine
    Dosage: as part of cop
    Indication: Burkitt's Lymphoma Stage III



Possible Prednisolone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 300 mg/m2 as part of cop
    Indication: Burkitt's Lymphoma Stage III

Cyclophosphamide
    Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2

Cytarabine
    Dosage: continuous infusion of 100 mg/m2 daily for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: administered once with hydrocortisone as part of cym1

Doxorubicin HCL
    Dosage: as part of copadm1
    Indication: Burkitt's Lymphoma Stage III

Doxorubicin HCL
    Dosage: as part of copadm2

Hydrocortisone
    Dosage: administered once with cytarabine as part of cym1

Hydrocortisone
    Dosage: administered with methotrexate
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm1

Methotrexate
    Dosage: as part of copadm2 and cym1

Methotrexate
    Dosage: administered with hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Prednisolone
    Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2

Prednisolone
    Dosage: 60 mg/m2/day for 7 days as part of cop
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: five total doses; cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm2

Vincristine
    Dosage: as part of cop
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm1



Possible Prednisolone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Pancytopenia, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 250 mg/m2, bid for 6 doses

Cyclophosphamide
    Dosage: 250 mg/m2, bid for 6 doses

Cyclophosphamide
    Dosage: 300 mg/m2, unk
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: 100 mg/m2, for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: unknown

Doxorubicin HCL
    Dosage: 30 mg/m2, unk

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Burkitt's Lymphoma Stage III

Hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Hydrocortisone
    Dosage: intrathecally twice

Hydrocortisone

Hydrocortisone
    Dosage: intrathecally twice

Hydrocortisone
    Dosage: unknwon

Methotrexate
    Dosage: 1500 mg/m2, unk

Methotrexate
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: intrathecally twice

Methotrexate
    Dosage: intrathecally twice

Methotrexate
    Dosage: 1500 mg/m2, unk

Methotrexate
    Dosage: 30000 mg/m2, unk

Methotrexate

Prednisolone
    Dosage: 60 mg/m2, for 5 days, then taper over 3 days

Prednisolone
    Dosage: 60 mg/m2, for 5 days then taper over 3 days

Prednisolone
    Dosage: 60 mg/m2, per day for 7 days
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: every 2-4 weeks for 5 total doses with cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: cumulative dose of 1875 mg/m2

Vincristine
    Dosage: 2 mg/m2, unk

Vincristine
    Dosage: 1 mg/m2, unk
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: 1 mg/m2, unk



Possible Prednisolone side effects in

Reported by a health professional (non-physician/pharmacist) from Ireland on 2012-06-20

Patient:

Reactions: Sepsis, Cytomegalovirus Infection, Human Polyomavirus Infection, Graft Loss

Adverse event resulted in: death

Drug(s) suspected as cause:
Azathioprine
    Indication: Prophylaxis Against Transplant Rejection

Azathioprine
    Administration route: Oral

Cellcept
    Indication: Prophylaxis Against Transplant Rejection

Prednisolone
    Dosage: for 2 days

Prednisolone
    Administration route: Oral

Prednisolone
    Indication: Prophylaxis Against Transplant Rejection

Prednisolone
    Administration route: Oral

Prednisolone
    Dosage: for 2 days

Tacrolimus

Tacrolimus
    Indication: Prophylaxis Against Transplant Rejection

Other drugs received by patient: Valtrex



Possible Prednisolone side effects in 76 year old female

Reported by a physician from Japan on 2012-06-19

Patient: 76 year old female

Reactions: Stomatitis, Small Intestinal Perforation, Pleurisy, Diarrhoea Haemorrhagic, Sepsis, Cholecystitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fludara
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2010-09-01
    End date: 2011-02-01

Prednisolone
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Recurrent

Rituximab
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2010-09-01
    End date: 2011-02-01



Possible Prednisolone side effects in

Reported by a physician from Japan on 2012-06-13

Patient:

Reactions: Jaundice, Stomatitis, Small Intestinal Perforation, Pleurisy, Sepsis, Diarrhoea Haemorrhagic, Cholecystitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fludara
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2010-09-01
    End date: 2011-02-01

Prednisolone
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Recurrent

Rituximab
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2010-09-01
    End date: 2011-02-01



Possible Prednisolone side effects in 68 year old male

Reported by a individual with unspecified qualification from Chile on 2012-06-05

Patient: 68 year old male

Reactions: Rectal Haemorrhage, Sepsis, Pancytopenia, Neutropenia, Ascites

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclosporine
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Methylprednisolone
    Indication: Diffuse Large B-Cell Lymphoma

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017